Form 4: HashiCorp's CTO, Armon Dadgar, Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


Armon Dadgar, CTO of HashiCorp, sold 35,904 shares of Class A Common Stock at an average price of $25.6905, executed under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On April 2, 2024, Armon Dadgar, the Chief Technology Officer of HashiCorp, sold 35,904 shares of Class A Common Stock.
  • The sale was executed under a Rule 10b5-1 trading plan adopted on September 7, 2023.
  • The shares were sold at a weighted average price of $25.6905, with individual transactions ranging from $25.06 to $25.95.
  • Following the transaction, Dadgar directly owns 118,864 shares of Class A Common Stock.
  • Dadgar also indirectly owns 1,661,164 shares through the Armon Dadgar 2020 Charitable Trust, 281,994 shares through the Armon Memaran-Dadgar Living Trust, and 90,440 shares through Black Swan III, LLC.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock sales by an executive. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.

Industry Context

Sales by company insiders are a common occurrence and are often viewed in the context of pre-planned trading programs like Rule 10b5-1 plans, which allow insiders to sell shares over a predetermined period to avoid accusations of trading on material non-public information. The market typically assesses the size and frequency of such sales to gauge potential impact.

Comparison to Industry Standards

  • Executive stock sales are a normal part of compensation and portfolio management.
  • Similar sales are seen at companies like Snowflake, Datadog, and CrowdStrike, where executives periodically exercise options or sell shares under 10b5-1 plans.
  • The scale of Dadgar's sale appears consistent with typical executive transactions at comparable tech companies.

Stakeholder Impact

  • The stock sale could have a minor impact on shareholders if it creates downward pressure on the stock price, although the existence of a 10b5-1 plan suggests the sales are planned and not based on current company performance.

Key Dates

DateDescription
09/07/2023Date of adoption of Rule 10b5-1 trading plan
04/02/2024Date of transaction (stock sale)
04/04/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.